The United States Patent and Trademark Office (USPTO) has granted patent US12582518B2 to TRICARES SAS for a novel heart valve prosthesis. This patent specifically covers a prosthesis designed with a variable sealing function, along with methods for its implantation and its application in treating heart valve disorders. The patent was filed on May 25, 2020, and officially granted on March 24, 2026.

This patent grant signifies the official recognition of TRICARES SAS's innovation in the field of cardiovascular prosthetics. While patent grants do not impose direct compliance obligations on other entities, they establish intellectual property rights that may affect market entry and product development for competitors in the medical device sector. Companies involved in the design, manufacturing, or sale of heart valve prostheses should be aware of this granted patent to ensure they do not infringe upon the assignee's exclusive rights.